![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Chronic Heart Failure |
Free Subscription
2 Am Heart J |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Chronic Heart Failure is free of charge.
The effect of tablet computer-based telemonitoring added to an established
telephone disease management program on heart failure hospitalizations: The
Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) III Randomized
Controlled Trial.
Am Heart J. 2023 Feb 24:S0002-8703(23)00042-X. doi: 10.1016/j.ahj.2023.
PubMed
Abstract available
Rationale and Study design of the GOREISAN for Heart Failure (GOREISAN-HF) trial:
A randomized clinical trial.
Am Heart J. 2023 Feb 23:S0002-8703(23)00045-5. doi: 10.1016/j.ahj.2023.
PubMed
Abstract available
Experience With SynCardia Total Artificial Heart as a Bridge to Transplantation
in 100 Patients.
Ann Thorac Surg. 2023;115:725-732.
PubMed
Abstract available
Univentricular Conversion for Acquired Severe Right Ventricular Failure.
Ann Thorac Surg. 2023;115:e75-e77.
PubMed
Abstract available
Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic
Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort.
Circ Arrhythm Electrophysiol. 2023 Jan 31:e011391.
PubMed
Abstract available
Prognostic Implications of Right Ventricular Size and Function in Patients
Undergoing Cardiac Resynchronization Therapy.
Circ Arrhythm Electrophysiol. 2023;16:e011676.
PubMed
Validation of a Polygenic Score for Beta-Blocker Survival Benefit in Patients
With Heart Failure Using the United Kingdom Biobank.
Circ Genom Precis Med. 2023 Mar 3:e003835. doi: 10.1161/CIRCGEN.121.003835.
PubMed
Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic
Right Ventricle: A Prospective Single-Center Study.
Circ Heart Fail. 2023;16:e009848.
PubMed
Abstract available
Characteristics and Outcome of Patients With a History of Cancer Undergoing
Durable Left Ventricular Assist Device Implantation.
Circ Heart Fail. 2023;16:e009772.
PubMed
Abstract available
Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction.
Circulation. 2023 Mar 1. doi: 10.1161/CIRCULATIONAHA.122.061846.
PubMed
Abstract available
Declining Risk of Sudden Cardiac Death in Heart Failure: Fact or Myth?
Circulation. 2023;147:759-767.
PubMed
Abstract available
Stages of Valvular Heart Disease Among Older Adults in the Community: The
Atherosclerosis Risk in Communities Study.
Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
PubMed
Abstract available
Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute
heart failure: A meta-analysis.
Clin Cardiol. 2023 Mar 2. doi: 10.1002/clc.23994.
PubMed
Electrocardiogram-based deep learning improves outcome prediction following
cardiac resynchronization therapy.
Eur Heart J. 2023;44:680-692.
PubMed
Abstract available
Endocrine functions of the heart: from bench to bedside.
Eur Heart J. 2023;44:643-655.
PubMed
Abstract available
A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose
vaccination in healthy persons.
Eur J Heart Fail. 2023;25:313-318.
PubMed
Abstract available
Association of post-vaccination adverse reactions after influenza vaccine with
mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular
disease: the INVESTED trial.
Eur J Heart Fail. 2023;25:299-310.
PubMed
Abstract available
Effect of beta-blocker therapy on the response to mavacamten in patients with
symptomatic obstructive hypertrophic cardiomyopathy.
Eur J Heart Fail. 2023;25:260-270.
PubMed
Abstract available
Incidence and clinical correlates of de-novo aortic regurgitation with a fully
magnetically levitated left ventricular assist device: a MOMENTUM 3 trial
portfolio analysis.
Eur J Heart Fail. 2023;25:286-294.
PubMed
Abstract available
Central haemodynamic abnormalities and outcome in patients with unexplained
dyspnoea.
Eur J Heart Fail. 2023;25:185-196.
PubMed
Abstract available
De novo aortic regurgitation related to left ventricular assist device therapy:
the difficult questions in need of new perspectives.
Eur J Heart Fail. 2023;25:295-298.
PubMed
Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers
blocking part of its shine?
Eur J Heart Fail. 2023;25:271-273.
PubMed
Are post-influenza vaccine reactions truly 'adverse'?
Eur J Heart Fail. 2023;25:311-312.
PubMed
Pulmonary vascular disease in heart failure with preserved ejection fraction: the
evidence grows.
Eur J Heart Fail. 2023 Feb 15. doi: 10.1002/ejhf.2800.
PubMed
Left atrial enlargement is associated with pulmonary vascular disease in heart
failure with preserved ejection fraction.
Eur J Heart Fail. 2023 Feb 27. doi: 10.1002/ejhf.2805.
PubMed
Abstract available
Inotropic therapy in patients with advanced heart failure. A clinical consensus
statement from the Heart Failure Association of the ESC.
Eur J Heart Fail. 2023 Feb 27. doi: 10.1002/ejhf.2814.
PubMed
Abstract available
Dosing of Iron Supplementation for Iron-Deficient Patients With Heart Failure:
Should We Prefer More Intensive or Less Intensive Repletion Targets?
Eur J Heart Fail. 2023 Feb 28. doi: 10.1002/ejhf.2816.
PubMed
Sex Differences in Heart Failure: The Evolving Use of Biomarkers.
Eur J Heart Fail. 2023 Feb 28. doi: 10.1002/ejhf.2817.
PubMed
Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
PubMed
Abstract available
Management of hospitalised patients with heart failure admitted to non-cardiology
services.
Heart. 2023 Feb 27:heartjnl-2022-321720. doi: 10.1136/heartjnl-2022-321720.
PubMed
Habitual physical activity levels of adults with heart failure: systematic review
and meta-analysis.
Heart. 2023 Feb 27:heartjnl-2022-321943. doi: 10.1136/heartjnl-2022-321943.
PubMed
Abstract available
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy
in Patients With Heart Failure.
J Am Coll Cardiol. 2023;81:849-863.
PubMed
Abstract available
Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing.
J Am Coll Cardiol. 2023;81:864-866.
PubMed
Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More
Data Are Needed.
J Am Coll Cardiol. 2023;81:e67.
PubMed
Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart
Failure: More Data Are Needed.
J Am Coll Cardiol. 2023;81:e69.
PubMed
Doing Harm by Doing No Harm? Resisting the urge to retire GDMT in older adults
with heart failure.
J Card Fail. 2023 Feb 23:S1071-9164(23)00058.
PubMed
Ventricular assist device for end-stage adult congenital heart disease patients:
Current status.
J Cardiol. 2023;81:378-384.
PubMed
Abstract available
Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary
vascular remodeling due to left heart disease in mice.
J Cardiol. 2023;81:347-355.
PubMed
Abstract available
Cost-effectiveness analysis of Empagliflozin in patients with heart failure with
reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
PubMed
Abstract available
Derivation and validation of a machine learning-based risk prediction model in
patients with acute heart failure.
J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by